Dr. Karl Dujardin SRL
Dr. Karl Dujardin reported total assets of €4.94m at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Jan 2026).
By total assets for 2025, Dr. Karl Dujardin ranks among the 100 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. Karl Dujardin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Karl Dujardin's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 26 Jan 2026
- Year ended 30 Jun 2024filed on 23 Jan 2025
- Year ended 30 Jun 2023filed on 29 Jan 2024
- Year ended 30 Jun 2022filed on 30 Jan 2023
- Year ended 30 Jun 2021filed on 27 Jan 2022
Dr. Karl Dujardin's financial analysis
- Solvency80.8%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Karl Dujardin
Dr. Karl Dujardin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0862.628.720
- VAT number
- BE0862628720
- Peppol
- Registered · 0208:0862628720 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Jan 2004
- Registered office
- 8800 Roeselare
- Latest accounts
- 2025 · filed on 26 Jan 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Karl Dujardin (SRL) has been based in Roeselare since 2004, active in: medical specialists activities. For 2025, it reports a net profit of 638,939 € and equity of €3.99m; its revenue is not published. Its solvency stands at 80.8%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Karl Dujardin
Companies in the same business, of comparable size and area, outside its group.
- SETO Activities of holding companies Ghent · balance sheet €5.66m
- Dokter Maes Bart Medical specialists activities Staden · balance sheet €5.04m
- SA Artsen Medical specialists activities Roeselare · balance sheet €3.72m
- JPS-60 Activities of holding companies Waasmunster · balance sheet €8.13m
- Dr. Brijs Stefaan, Medische Beeldvorming Medical specialists activities Nazareth-De Pinte · balance sheet €2.57m
- Dr. L. Delsupehe Medical specialists activities Roeselare · balance sheet €2.64m
- DRS. Verfaillie - van Pelt Medical specialists activities Roeselare · balance sheet €3.95m
- Ophtalmologie Chirurgicale Van Cauwenberge Rakic Medical specialists activities Liège · balance sheet €7.10m
Frequently asked questions about Dr. Karl Dujardin
What is the revenue of Dr. Karl Dujardin?
Dr. Karl Dujardin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Karl Dujardin?
In Belgium, the VAT number is the company number prefixed with BE: BE0862628720 for Dr. Karl Dujardin, if the company is VAT-registered. Its company number (CBE) is 0862.628.720.
Where is the registered office of Dr. Karl Dujardin?
According to the CBE register, the registered office of Dr. Karl Dujardin is in 8800 Roeselare.
What is the equity of Dr. Karl Dujardin?
At the close of the 2025 financial year, the equity of Dr. Karl Dujardin amounts to 3,988,183 €, a solvency of 80.8% of total assets.
Who manages Dr. Karl Dujardin?
The register lists 2 active mandates at Dr. Karl Dujardin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. Karl Dujardin within its sector?
By total assets for 2025, Dr. Karl Dujardin ranks among the 100 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr. Karl Dujardin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →